Invention Grant
- Patent Title: Nucleoside phosphoramidates
- Patent Title (中): 核苷氨基磷酸酯
-
Application No.: US13732725Application Date: 2013-01-02
-
Publication No.: US09206217B2Publication Date: 2015-12-08
- Inventor: Bruce Ross , Michael Joseph Sofia , Ganapati Reddy Pamulapati , Suguna Rachakonda , Hai-Ren Zhang , Byoung-Kwon Chun , Peiyuan Wang
- Applicant: GILEAD PHARMASSET LLC
- Applicant Address: US CA Foster City
- Assignee: Gilead Pharmasset LLC
- Current Assignee: Gilead Pharmasset LLC
- Current Assignee Address: US CA Foster City
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: C07H19/00
- IPC: C07H19/00 ; C07H19/10 ; A61K31/7072 ; A61K45/00 ; C07F9/24 ; A61K31/716 ; C07H17/02 ; C07F9/6558
Abstract:
Disclosed herein are nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent 5 RNA viral replication and are useful as inhibitors of HCV NS5B polymerase, as inhibitors of HCV replication and for treatment of hepatitis C infection in mammals.
Public/Granted literature
- US20130165401A1 NUCLEOSIDE PHOSPHORAMIDATES Public/Granted day:2013-06-27
Information query
